bioRxivPhysiology
Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression
K. K. Mattis, N. A. J. Krentz, C. Metzendorf, F. Abaitua, A. F. Spigelman, H. Sun, A. K. Rottner, A. Bautista, E. Mazzaferro, M. Perez-Alcantara, J. E. Manning Fox, J. M. Torres, A. Weslowska-Andersen, G. Z. Yu, A. Mahajan, A. Larsson, P. E. MacDonald, B. Davies, M. den Hoed, A. L. Gloyn
Abstract
Aims/hypothesisGenome-wide studies have uncovered multiple independent signals at the RREB1 locus associated with altered type 2 diabetes risk and related glycemic traits. However, little is known about the function of the zinc finger transcription factor RREB1 in glucose homeostasis or how changes in its expression and/or function influence diabetes risk. MethodsA zebrafish model lacking rreb1a and rreb1b was used to study the effect of RREB1 loss in vivo. Using transcriptomic and cellular phenotyping of a human beta cell model (EndoC-{beta}H1) and human induced pluripotent stem cell (hiPSC)-derived beta-like cells, we investigated how loss of RREB1 expression and activity affects pancreatic endocrine cell development and function. Ex vivo measurements of human islet function were performed in donor islets from carriers of RREB1 T2D-risk alleles. ResultsCRISPR-Cas9-mediated loss of rreb1a and rreb1b function in zebrafish supports an in vivo role for the transcription factor in beta cell mass, beta cell insulin expression, and glucose levels. Loss of RREB1 reduced insulin gene expression and cellular insulin content in EndoC-{beta}H1 cells, and impaired insulin secretion under prolonged stimulation. Transcriptomic analysis of RREB1 knockdown and knockout EndoC-{beta}H1 cells supports RREB1 as a novel regulator of genes involved in insulin secretion. In vitro differentiation of RREB1KO/KO hiPSCs revealed a dysregulation of pro-endocrine cell genes, including RFX family members, suggesting that RREB1 also regulates genes involved in endocrine cell development. Human donor islets from carriers of T2D-risk alleles in RREB1 have altered glucose-stimulated insulin secretion ex vivo, consistent with RREB1 regulating islet cell function. Conclusions/interpretationTogether, our results indicate that RREB1 regulates beta cell function by transcriptionally regulating the expression of genes involved in beta cell development and function. Research in contextO_ST_ABSWhat is already known about this subject?C_ST_ABSO_LIHuman genetic variation in RREB1 is associated with altered diabetes risk, variation in glycemic, and anthropometric traits C_LIO_LIRREB1 is a transcription factor that binds to Ras-responsive elements and is expressed in multiple diabetes relevant tissues, including pancreatic islets C_LI What is the key question?O_LIHow does altered expression or function of RREB1 influence diabetes risk? C_LI What are the new findings?O_LIKnockdown and knockout of RREB1 in mature human EndoC-{beta}H1 cells reduces expression of insulin transcript and cellular content, as well as insulin secretion under prolonged stress C_LIO_LICarriers of the T2D-risk RREB1 coding allele trend towards reduced insulin content, but have improved glucose-stimulated insulin secretion C_LIO_LIA loss-of-function zebrafish model suggests that RREB1 is required for insulin expression C_LI How might this impact on clinical practice in the foreseeable future?O_LIRREB1 controls beta cell function and whole-body glucose homeostasis by transcriptionally regulating the development and function of pancreatic beta cells C_LI
- organism: human
- organism: zebrafish
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of RREB1 reduces adipogenesis and improves insulin sensitivity in mouse and human adipocytes
Grace Zhuo Yu, Nicole A. J. Krentz, … Anna L. Gloyn·bioRxiv·Jul 30, 2024
- A crosstalk between E2F1 and GLP-1 signaling pathways modulates insulin secretion
C. Bourouh, E. Courty, … J.-S. Annicotte·bioRxiv·Apr 16, 2021
- RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell functionality
H. Ibrahim, D. Balboa, … T. Otonkoski·bioRxiv·Nov 15, 2023
- C3aR1 on β cells enhances β cell function and survival
Renan Pereira de Lima, Ang Li, … James C. Lo·Molecular MetabolismPeer-reviewed·Apr 6, 2025
- Molecular Correlates of Glycine Receptor Activity in Human β Cells
Amanda Schukarucha Gomes, Cara E. Ellis, … Patrick E. MacDonald·Molecular MetabolismPeer-reviewed·Apr 19, 2025
- RFX6-mediated dysregulation defines human β cell dysfunction in early type 2 diabetes
J. T. Walker, D. C. Saunders, … M. Brissova·bioRxiv·Dec 16, 2021